What are the precise inflammatory signaling cascades linking microglial activation to neuronal loss in AD, and can specific nodes be targeted without immunosuppression?

While inflammation is recognized as a pathomechanism, the specific molecular mechanisms by which chronic neuroinflammation drives tau aggregation and synaptic loss remain undefined. Current anti-inflammatory approaches have failed in trials, suggesting we lack mechanistic resolution of which inflammatory pathways are protective vs. destructive.